Summary In a retrospective study of the mutational spectrum of the p53 gene in oral squamous cell carcinoma, 80 primary tumours diagnosed in 1980-90 were included. Using polymerase chain reaction/single strand conformation polymorphism (PCR/SSCP) analysis 47 mutations were found distributed in 39 of the tumours (49%). Unexpectedly, the majority of the mutations (29/47; 62%) were found in exon 8, and at sequencing 17 of them showed a 14 bp deletion in codons 287-292, causing formation of a stop codon and accordingly a truncated protein lacking the C-terminal. The majority of the patients with the 14 bp deletion were women (13/17), and it seemed as though certain potential risk factors for carcinoma of the head and neck were less common in this group.
The p53 protein, encoded by the tumour-suppressor gene p53, encompasses three distinct regions: (1) the amino-terminus with a transactivation domain (codons 20-42); (2) the midregion with a sequence-specific DNA binding domain (codons 100-293) and (3) the carboxy-terminus with a nuclear localisation domain (codons 316 -325) and an oligomerisation domain (codons 319-360) (Greenblatt et al., 1994) . In the mid-region, four of the five evolutionary conserved domains are found. The wild-type p53 protein acts as a transcription factor capable of activating transcription of certain genes such as mdm2 (Momand et al., 1992; , WAF1/Cipl (El-Deiry et al., 1993; Harper et al., 1993) and Gadd45 (Carrier et al., 1994) . Mdm2 is an oncogene that exerts negative feedback on p53 (Momand et al., 1992; , WAF1/Cipl is an inhibitor of cyclin-dependent kinases (El-Deiry et al., 1993; Harper et al., 1993) and Gadd45 is capable of blocking progression through the cell cycle in GI, a process reversible by mdm2 (Levine et al., 1994) . p53 also controls the cell cycle as 'guardian of the genome' (Lane, 1992) , and in UV-damaged skin it is considered 'guardian of the tissue ' (Ziegler et al., 1994) inducing apoptosis in sunburn cells.
Mutations in the p53 gene are frequent in human cancer, mostly affecting the conserved parts of the protein. The importance of p53 mutations in human tumours is, however, not fully understood. In breast carcinomas, p53 mutation has been suggested as an important indictaor of short-term survival (Thorlacius et al., 1993) , whereas p53 gene mutations and deletions so far have not shown any association with disease progression in squamous cell carcinoma of the head and neck (SCCHN) (Ahomadegbe et al., 1995) .
In SCCHN, mutations in the p53 gene have been found in around 40-50% of the tumours (Boyle et al., 1993; Brachman et al., 1992; Brennan et al., 1995; Nylander et al., 1995) .
Codons 238-248 and 278-281 have been pinpointed as hotspots for these mutations (Field et al., 1993; Sakai and Tsuchida, 1992; Somers et al., 1992) . p53 mutations seem to be dependent on epidemiological factors, e.g. geographic origin which in hepatocellular carcinoma has been shown to be a factor affecting the mutational spectrum of p53 (Greenblatt et al., 1994) . The spectrum has also been found to vary between different countries and races in SCCHN. Thus, mutations have most frequently been found in exon 7 in the USA, whereas exon 8 was more frequently mutated in Japan (Field et al., 1993; Sakai and Tsuchida, 1992; Somers et al., 1992) . On the whole, approximately 98% of all p53 mutations in SCCHN are found within exons 5-8 (Greenblatt et al., 1994) . The mutational pattern in SCCHN may also be influenced by exogenous carcinogens, such as mutagens in cigarette smoke, e.g. benzo(a)pyrene, that preferentially induce transversions (G:C-+T:A) (Puisieux et al., 1991) . Furthermore, the spectrum of p53 mutations is wider in cigarette smokers who also drink alcohol, whereas p53 mutations in non-smokers/non-drinkers predominate at CpG sites which are suggested as endogenous mutational 'hotspots' (Brennan et al., 1995) .
Mutations in the p53 gene are mainly of missense type, constituting up to 79-86% of all mutations (Greenblatt et al., 1994; Levine et al., 1994) , whereas only approximately 8% of all mutations found are deletions and insertions (Levine et al., 1994) . In SCCHN deletions have, however, been found in a higher frequency constituting up to 30% of all mutations (Brachman et al., 1992; Burns et al., 1993) . The obvious predominance of missense over non-missense mutations is, however, only seen between codons 130 and 286 (Greenblatt et al., 1994) . In an earlier study of p53 mutations in SCCHN we found a deletion of 14 bp in exon 8 in one tumour (Nylander et al., 1995) . Big deletions have been reported in other studies of SCCHN (Ahomadegbe et al., 1995; Magnusson et al., 1995; Zariwala et al., 1994) as well as in other tumours, such as colon cancer, breast cancer, leukaemia and oesophageal carcinoma (Jego et al., 1993; Huang et al., 1994) .
In the present expanded study we investigated the mutational spectrum of the p53 gene in 80 primary oral squamous cell carcinomas diagnosed in the period [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] [1990] in the northern part of Sweden. In this paper we report the finding of a specific 14 bp deletion in exon 8 that we correlated with epidemiological data collected from these patients.
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off with a scalpel. Depending on the size of the tumour, two to five 10-pm sections were cut from each sample. For each block a new microtome knife blade was used, and sections were put in sterile tubes using a tweezer which was washed in xylol between sectioning of each block. DNA was extracted according to Shibata (1992 (Wright and Manos, 1990 ).
Primers
Exons 5-9 of the p53 gene were amplified from each tumour using primers earlier characterised (Gaidano et al., 1991 An alternative PCR programme was applied for samples that had not amplified and were resectioned. In this programme a 'hot start' at 94°C for 10 min was followed by 40 cycles with denaturation at 94°C for 1 min, annealing at 55°C for 1 min and extension at 72°C for 2 min. The last cycle was followed by a final extension at 72°C for 5 min (Wright and Manos, 1990) . The reason for prolonged times for denaturation and extension is that amplification from prepared paraffin-embedded tissue has been found to be less efficient than amplification of DNA from fresh tissue (Wright and Manos, 1990 ).
Reaction mixture (2 pl) was diluted with 50 pl 0.1% sodium dodecyl sulphate (SDS)/10 mM EDTA and 52 pl 98% formamide, 0.05% bromophenol blue, 0.05% xylene cyanol and 20 mM sodium hydroxide. This mixture was heated at 95°C for 5 min and chilled on ice, then 3 pl was loaded in each lane of a 6% polyacrylamide/TBE gel with 10% glycerol. Gels were run at room temperature at 3 W for [16] [17] [18] [19] [20] h, and autoradiography was performed at -70°C for 4-48 h.
Cloning and sequencing of PCR products After the initial PCR/SSCP analysis of all tumours was finished a new non-radioactive PCR reaction was performed for tumours to be sequenced. This reaction amplifying the mutated exon was performed as described above with a higher concentration of dNTPs (200 pM x x x p53 in oral squamous cell carcinoma K Nylander et al ! 1383 consistent, whereas two variable band patterns for the normal control samples were found, one of these concordant with the pattern for the 14 bp deletion. Out of the three tumours with a point mutation (C--T) in different codons mutation could be detected in one case due to aberrant band pattern, whereas the other two tumours showed no aberration. A reduction in mutation-induced mobility change is often found when the amplified product exceeds 180 bp (Moyret et al., 1994) . This could explain the difficulty we had in differentiating between these new products being up to 281 bp in length. Amplification of these long fragments could not be achieved in all tumours, possibly owing to the formaldehyde fixation (Karlsen et al., 1994) .
In another control series all steps from sectioning and DNA extraction to mixing new reactions with fresh ingredients were performed in another laboratory, giving the same pattern on SSCP gels as found in the initial analysis (Figure 3) . PCR products from tumours with the 14 bp deletion gave two distinct bands on agarose gel compared with one band for normal samples and samples with other mutations (Figure 4) .
Additional samples taken at the same time as the initial biopsy were available from five patients. When analysing these samples, six additional mutations were found. In one Table I ); lane 3, tumour with 14bp deletion, codons 287-292 (tumour 16 in Table I ); lane 4, non-mutated tumour; lane 5, tumour with 14bp deletion, codons 287-292 (tumour 17 in Table I ). Table I ). The presence of two mutations in this tumour explains why the lowest band is not co-localised with the corresponding band in the other tumours with the 14bp deletion; lane 2, tumour with the 14 bp deletion (tumour 4 in Table I ); lane 3, new sections from the same tumour as in lane 2, showing the same pattern with somewhat weaker aberrant bands. This is explained by the fact that this part of the sample contained less tumour tissue; lane 4, tumour with the 14bp deletion (tumour 17 in Table I ). The initial analysis of the same tumour is shown in lane 5 in Figure 1 ; lane 5, normal placenta sample. Table I ). (Field et al., 1993; Sakai and Tsuchida, 1992; Somers et al., 1992 The non-existence of the same 14 bp deletion in samples from ulcerative colitis and colon carcinoma run at the same time using the same equipment and ingredients furthermore contradicts any possible contamination and confirms the true nature of this novel deletion in oral squamous cell carcinoma.
One explanation for the 14 bp deletion could be the close proximity of three GA dinucleotides in the area, one located just outside the deletion and the other two at each end of the deletion. This might cause erroneous reannealing between the first repeat and the complementary strand of the third repeat when the DNA chain opened before replication (Jego et al., 1993) . Thus, a loop consisting of the two other GA dinucleotides and the sequence in between was formed and excised before actual replication occurred.
The primary effect of the 14 bp deletion is the formation of a stop codon, and accordingly a truncated protein with loss of the C-domain containing the oligomerisation domain and the nuclear localisation signals (NLS). In vitro tetramerisation is not essential for DNA binding of p53, whereas at least dimerisation is necessary for p53 activity in vivo (Jeffrey et al., 1995) . For retaining the transactivational activity the location of the truncation is of importance (Crook et al., 1994) . Appreciable DNA binding and transactivation has been found after deletion of up to 87 residues from the C-terminal (Shaulian et al., 1995) , near truncation caused by the 14 bp deletion. The mutation we found could theoretically cause production of a p53 protein incapable of transactivation accumulating in the cytoplasm, as it is lacking the NLS. A protein lacking the NLS is, however, not ultimately located in the cytoplasm, as wildtype p53 devoid of NLS in vitro has been shown to complex with another nuclear protein, and thereby entered the nucleus (Shaulsky et al., 1990) . Immunohistochemical staining of the tumours in this material with an antibody against p53 showed nuclear as well as cytoplasmic staining in three of the tumours with the 14 bp deletion. Cytoplasmic staining was, however, also found in four other tumours, three without any mutation at all and one with a mutation in exon 6. This makes it less probable that the p53 protein found in the cytoplasm of tumours with the deletion was accumulated truncated protein. In the immunohistochemical analysis 10 of the 17 tumours with the 14 bp deletion showed a positive staining, whereas seven tumours were negative. This can be explained by the sensitivity of the PCR/SSCP technique by which mutations can be detected with an admixture of up to 85-95% normal non-mutated cells (Wu JK et al., 1993) . Accordingly wild-type p53 protein or wild-type p53 protein bound to another protein found in some tumour cells or in normal admixing cells could cause a negative or positive staining respectively.
In conclusion, in this study a new non-random deletion in exon 8 in oral squamous cell carcinomas was found. The validity of this finding was confirmed by extensive control experiments. The cause and clinical significance of this new 14 bp deletion is so far not known. Of patients with the deletion 80% were women, and there was a tendency for later onset of the disease. In order to characterise this new group of patients as thoroughly as possible, exposure to different factors was investigated. There is, to our knowledge, no scientific basis for the association between dental treatment and p53 mutations, but the deletion group differed significantly from the other patients concerning filling material. Our data for this group furthermore implicated a possible independence of known risk factors for SCCHN, such as smoking.
